These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8086768)

  • 21. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
    Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody responses to preS components after immunization of children with low doses of BioHepB.
    Madalinski K; Sylvan SP; Hellström U; Mikolajewicz J; Zembrzuska-Sadkowska E; Piontek E
    Vaccine; 2001 Oct; 20(1-2):92-7. PubMed ID: 11567751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of protection level of anti-pre-S2 antibodies in humans immunized with a novel hepatitis B vaccine consisting of M (pre-S2 + S) protein particles (a third generation vaccine).
    Kuroda S; Fujisawa Y; Iino S; Akahane Y; Suzuki H
    Vaccine; 1991 Mar; 9(3):163-9. PubMed ID: 1828318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B Vaccination in Patients Receiving Oral Antiviral Therapy Without Hepatitis B Immunoglobulin After Liver Transplant.
    Wong TCL; Fung JYY; Chok KSH; Cheung TT; Chan ACY; Dai WC; Ng KKC; Chan SC; Lo CM
    Transplant Proc; 2018 Dec; 50(10):3681-3688. PubMed ID: 30577255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association of the vitamin D status with the persistence of anti-HBs antibody at 20years after primary vaccination with recombinant hepatitis B vaccine in infancy.
    Jafarzadeh A; Keshavarz J; Bagheri-Jamebozorgi M; Nemati M; Frootan R; Shokri F
    Clin Res Hepatol Gastroenterol; 2017 Feb; 41(1):66-74. PubMed ID: 27459879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful immune response to a recombinant hepatitis B vaccine in children after liver transplantation.
    Duca P; Del Pont JM; D'Agostino D
    J Pediatr Gastroenterol Nutr; 2001 Feb; 32(2):168-70. PubMed ID: 11321387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune response of immunocompromised children with malignancies to a recombinant hepatitis B vaccine.
    Polychronopoulou-Androulakaki S; Panagiotou JP; Kostaridou S; Kyratzopoulou A; Haidas S
    Pediatr Hematol Oncol; 1996; 13(5):425-31. PubMed ID: 10897814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of B and T-cell responses in chimpanzees immunized with Hepagene, a hepatitis B vaccine containing pre-S1, pre-S2 gene products.
    Pride MW; Bailey CR; Muchmore E; Thanavala Y
    Vaccine; 1998 Apr; 16(6):543-50. PubMed ID: 9569463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dissociated antibody responses to the S and pre-S2 regions of the hepatitis B virus after vaccination in hemophiliacs.
    Zanetti A; Tanzi E; Mannucci PM
    J Med Virol; 1989 Jul; 28(3):156-8. PubMed ID: 2526861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S vaccine.
    Shouval D; Roggendorf H; Roggendorf M
    Med Microbiol Immunol; 2015 Feb; 204(1):57-68. PubMed ID: 25557605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in children.
    Raz R; Dagan R; Gallil A; Brill G; Kassis I; Koren R
    Vaccine; 1996 Feb; 14(3):207-11. PubMed ID: 8920701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
    Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
    Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B Virus Revaccination With Standard Versus Pre-S Vaccine in Previously Immunized Patients With Celiac Disease.
    Heshin-Bekenstein M; Turner D; Shamir R; Bar-Meir M; Dagan R; Zevit N; Silbermintz A
    J Pediatr Gastroenterol Nutr; 2015 Oct; 61(4):400-3. PubMed ID: 25988560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Duration of protection after infant hepatitis B vaccination series.
    Middleman AB; Baker CJ; Kozinetz CA; Kamili S; Nguyen C; Hu DJ; Spradling PR
    Pediatrics; 2014 Jun; 133(6):e1500-7. PubMed ID: 24843060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response to an extra dose of hepatitis B vaccine and specific antibody persistence in non-responders to primary immunization.
    Chiaramonte M; Ngatchu T; Majori S; Baldo V; Moschen ME; Renzulli G; Trivello R
    Scand J Gastroenterol; 1995 Jun; 30(6):601-3. PubMed ID: 7569770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral administration of a chimeric Hepatitis B Virus S/preS1 antigen produced in lettuce triggers infection neutralizing antibodies in mice.
    Dobrica MO; Lazar C; Paruch L; van Eerde A; Clarke JL; Tucureanu C; Caras I; Ciulean S; Onu A; Tofan V; Branzan A; Urban S; Stavaru C; Branza-Nichita N
    Vaccine; 2018 Sep; 36(38):5789-5795. PubMed ID: 30082163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of four recombinant hepatitis B vaccines applied on an accelerated schedule in healthy adults.
    Hernández-Bernal F; Aguilar-Betancourt A; Aljovin V; Arias G; Valenzuela C; de Alejo KP; Hernández K; Oquendo O; Figueredo N; Figueroa N; Musacchio A; Véliz G; García E; Mollineda AD; Juvier AI; Trujillo J; Delahanty A; Ortega D; Cinza Z; González VL
    Hum Vaccin; 2011 Oct; 7(10):1026-36. PubMed ID: 21941089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid seroprotection against hepatitis B following the first dose of a Pre-S1/Pre-S2/S vaccine.
    Shapira MY; Zeira E; Adler R; Shouval D
    J Hepatol; 2001 Jan; 34(1):123-7. PubMed ID: 11211888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physicochemical and immunological characterization of hepatitis B virus envelope particles exclusively consisting of the entire L (pre-S1 + pre-S2 + S) protein.
    Yamada T; Iwabuki H; Kanno T; Tanaka H; Kawai T; Fukuda H; Kondo A; Seno M; Tanizawa K; Kuroda S
    Vaccine; 2001 Apr; 19(23-24):3154-63. PubMed ID: 11312011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the T- and B-cell immune response to a new recombinant pre-S1, pre-S2 and SHBs antigen containing hepatitis B vaccine (Hepagene); evidence for superior anti-SHBs antibody induction in responder mice.
    Jones CD; Page M; Bacon A; Cahill E; Bentley M; Chatfield SN
    J Viral Hepat; 1998 Nov; 5 Suppl 2():5-8. PubMed ID: 9857353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.